# Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure

> **NCT03863002** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tianjin Weikai Bioeng., Ltd.** · enrollment: 45 (estimated)

## Conditions studied

- Liver Failure, Acute on Chronic

## Interventions

- **BIOLOGICAL:** Mesenchymal Stem Cell

## Key facts

- **NCT ID:** NCT03863002
- **Lead sponsor:** Tianjin Weikai Bioeng., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2021-10-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2019-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03863002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03863002, "Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03863002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*